PL2801352T3 - Ulegające rozpadowi w jamie ustnej formulacje lakozamidu - Google Patents

Ulegające rozpadowi w jamie ustnej formulacje lakozamidu

Info

Publication number
PL2801352T3
PL2801352T3 PL14167375T PL14167375T PL2801352T3 PL 2801352 T3 PL2801352 T3 PL 2801352T3 PL 14167375 T PL14167375 T PL 14167375T PL 14167375 T PL14167375 T PL 14167375T PL 2801352 T3 PL2801352 T3 PL 2801352T3
Authority
PL
Poland
Prior art keywords
lacosamid
orally disintegrating
disintegrating formulations
formulations
orally
Prior art date
Application number
PL14167375T
Other languages
English (en)
Inventor
Ali Türkyilmaz
Ali Hasan Turp
Uzunogullar Nur Kirat
Yildiz Gülkok
Mehtap Saydam
Melike Eceoglu
Original Assignee
Sanovel Ilac Sanayi Ve Ticaret A.S.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanovel Ilac Sanayi Ve Ticaret A.S. filed Critical Sanovel Ilac Sanayi Ve Ticaret A.S.
Publication of PL2801352T3 publication Critical patent/PL2801352T3/pl

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0053Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/16Amides, e.g. hydroxamic acids
    • A61K31/165Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2004Excipients; Inactive ingredients
    • A61K9/2013Organic compounds, e.g. phospholipids, fats
    • A61K9/2018Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2072Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2077Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
    • A61K9/2081Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets with microcapsules or coated microparticles according to A61K9/50
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/141Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
    • A61K9/146Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic macromolecular compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005Wall or coating material
    • A61K9/5021Organic macromolecular compounds
    • A61K9/5026Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Zoology (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Preparation (AREA)
PL14167375T 2013-05-08 2014-05-07 Ulegające rozpadowi w jamie ustnej formulacje lakozamidu PL2801352T3 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
TR201305490 2013-05-08
TR201305664 2013-05-13
EP14167375.6A EP2801352B1 (en) 2013-05-08 2014-05-07 Orally disintegrating formulations of Lacosamid

Publications (1)

Publication Number Publication Date
PL2801352T3 true PL2801352T3 (pl) 2017-12-29

Family

ID=50630711

Family Applications (1)

Application Number Title Priority Date Filing Date
PL14167375T PL2801352T3 (pl) 2013-05-08 2014-05-07 Ulegające rozpadowi w jamie ustnej formulacje lakozamidu

Country Status (4)

Country Link
EP (1) EP2801352B1 (pl)
ES (1) ES2643287T3 (pl)
PL (1) PL2801352T3 (pl)
WO (1) WO2014180920A1 (pl)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3397253A1 (en) 2015-12-30 2018-11-07 Adamas Pharmaceuticals, Inc. Methods and compositions for the treatment of seizure-related disorders

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20090298947A1 (en) * 2008-05-28 2009-12-03 Pliva Hrvatska D.O.O. Polymorphic and amorphous forms of lacosamide and amorphous compositions
DE102008059155A1 (de) * 2008-11-27 2010-06-02 Ratiopharm Gmbh Trockenverarbeitung und neue Formen von Lacosamid
WO2011055385A1 (en) * 2009-11-03 2011-05-12 Lupin Limited Modified release formulation of lacosamide
WO2011130615A2 (en) * 2010-04-15 2011-10-20 Dr. Reddy's Laboratories Ltd. Preparation of lacosamide
EP2468261A1 (en) * 2010-12-02 2012-06-27 UCB Pharma GmbH Formulation of lacosamide

Also Published As

Publication number Publication date
WO2014180920A1 (en) 2014-11-13
EP2801352A1 (en) 2014-11-12
ES2643287T3 (es) 2017-11-22
EP2801352B1 (en) 2017-07-05

Similar Documents

Publication Publication Date Title
ZA201501847B (en) Formulations of enzalutamide
GB201319791D0 (en) Formulations
GB201421334D0 (en) Synthesis of aeizeolite
IL240797A0 (en) Defrasirox preparations for oral administration
IL245855B (en) Oral formulations of pyrrolidine derivatives
GB201319792D0 (en) Formulations
IL245420A0 (en) New formulations
GB2539112B (en) Chlorination of sucrose-6-esters
ZA201505082B (en) Sustained release formulations of lorazepam
GB2516028B (en) Improved structure of shoe
PL2801352T3 (pl) Ulegające rozpadowi w jamie ustnej formulacje lakozamidu
PL2848260T3 (pl) Nowe formulacje tiokolchikozydu
TWM475821U (en) Structure of mosquito-catch
PL3071575T3 (pl) Wytwarzanie normorfinanów
GB201304608D0 (en) BenTime of Yisrael operable arrangement
TWM475524U (en) Structure of rivet-pulling
GB201322366D0 (en) Chlorination of sucrose-6-esters
GB201314779D0 (en) Chlorination of sucrose-6-esters